DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20160878
Published: 2016-12-27

Outcome of treatment of vulvodynia by local application of anaesthetic agent

Pratiksha Gupta, Chandana Shekhar

Abstract


Background: Vulvodynia is a chronic gynecological disorder. It has a widespread effect on quality of life due to physical disabilities, psychological distress and sexual dysfunction. The objective of the study was to assess the effectiveness of application of 5% Xylocaine ointment for treatment of Vulvodynia.

Methods: This prospective study was conducted in the department of Obstetrics and Gynecology in Government Medical College and Hospital Chandigarh, from November 2004 to October 2010. Study included 520 female patients (age range, 20–65 years; mean, 32.50 years) with the diagnosis of Vulvodynia. Vulvodynia was measured by using Friedrich criteria. Daily and intercourse related pain was measured using a 10-mm visual analogue scale. Comparison was done between ability to have intercourse and pain ratings before and after the treatment.

Results: After a mean of 8 weeks’ treatment, the daily pain rating was 10.37 points lower as compared to pretreatment phase. The intercourse-related pain score was 39.11 points lower after treatment. After six months of follow-up, eighty-eight percent (458/520) of women reported ability to have intercourse after treatment compared with 34% 177/520) at the initial visit. Visual analogue score of 520 patients were significantly reduced from 8.6 to 2.5 after post treatment.

Conclusions: Topical 5% Xylocaine ointment was associated with an improvement in symptoms in the majority of women with Vulvodynia.

Keywords


Vulvodynia, Women, Vaginal mucosa, 5% Xylocaine

Full Text:

PDF

References


Petersen CD, Lundvall L, Kristensen E, Giraldi A. Vulvodynia. Definition, diagnosis and treatment. Acta Obstet Gynecol Scand. 2008;87(9):893-901.

Arnold LD, Bachmann GA, Rosen R, Kelly S, Rhoads GG. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006;107(3):617-24.

Hengge UR, Runnebaum IB. Vulvodynia. Hautarzt 2005;56(6):556-9.

Reed BD, Haefner HK, Edwards L. A survey on diagnosis and treatment of Vulvodynia among Vulvodynia researchers and members of the International Society for the Study of Vulvovaginal Disease. J Reprod Med. 2008;53(12):921-9.

Lotery HE, McClure N, Galask RP. Vulvodynia. Lancet. 2004;363:1058-60.

Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of Vulvodynia. Int J Impot Res. 2007;19:84-7.

Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med. 1987;32:110-4.

Masheb RM, Kerns RD, Lozano C, Minkin MJ, Richman S. A randomized clinical trial for women with Vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy. Pain. 2009;141(1-2):31-40.

Hartmann D, Strauhal MJ, Nelson CA. Treatment of women in the United States with localized, provoked Vulvodynia: practice survey of women's health physical therapists. J Reprod Med. 2007;52(1):48-52.

Murina F, Bernorio R, Palmiotto R. The use of amielle vaginal trainers as adjuvant in the treatment of vestibulodynia: an observational multicentric study. Medscape J Med. 2008;10(1):23.

Backman H, Widenbrant M, Bohm-Starke N, Dahlof LG. Combined physical and psychosexual therapy for provoked vestibulodynia-an evaluation of a multidisciplinary treatment model. J Sex Res. 2008;45(4):378-85.

McCormack WM, Spence MR. Evaluation of the surgical treatment of Vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol. 1999;86(2):135-8.

Bergeron S, Bouchard C, Fortier M, Binik YM, Khalife S. The surgical treatment of Vulvar vestibulitis syndrome: a follow-up study. J Sex Marital Ther. 1997;23(4):317-25.

Eva LJ, Narain S, Orakwue CO, Luesley DM. Is modified vestibulectomy for localized provoked Vulvodynia an effective long-term treatment? A follow-up study. J Reprod Med. 2008;53(6):435-40.

Leclair CM, Goetsch MF, Lee KK, Jensen JT. KTP-nd: YAG laser therapy for the treatment of vestibulodynia: a follow-up study. J Reprod Med. 2007;52(1):53-8.

Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol. 2008;112:231-7.

Bergeron S, Binik YM, Khalife S, Pagidas K. Vulvar vestibulitis syndrome: a critical review. Clin J Pain. 1997;13(1):27-42.

Ehrstrom S, Kornfeld D, Rylander E, Bohm-Starke N. Chronic stress in women with localised provoked Vulvodynia. J Psychosom Obstet Gynaecol. 2009;30(1):73-9.

Reese JB. Results from an RCT testing a psychosocial treatment for Vulvodynia: Methodological strengths and future directions. Pain. 2009;141(1-2):8-9.

Rowbotham MC, Fields HL. Topical Xylocaine reduces pain in post-herpetic neuralgia. Pain. 1989;38:297-301.